They've already said they have enough cash to get them through the FDA decision. That is all that matters RIGHT NOW imo. Rest assured that a partnership deal, licensing deal or buy-out would be almost certain w/approval! I have no proof but would find it hard to believe there is no talking going on behind the scenes. Floundering around down here like some dead fish makes a buy-out seem like the logical route. Someone going to get this company cheap, cheap, cheap!!!! IF it gets the ax then all bets are off for awhile. I think we'll know with a month or so.
Northland's target is $7 and although Kalia says that the firm "can articulate on DCF's as to how [the] price target was achieved ... ETRM could now be a good takeout target post-approval."
I'm sure the pps would take a hit. But ETRM is not dead if not approved. They are in business overseas, they just need to get the reimbursement issues taken care of. Is the company not worth $100M with an approved device in other parts of the world?
Roth Capital Partners has raised its price target for “buy-rated” EnteroMedics (NASDAQ:ETRM) to $5 from $3 after the FDA’s Gastroenterology-Urology Device Advisory Panel voted that the benefits of the company’s Maestro System outweigh the risks by a margin of six-to-two, with one abstention.
With the positive risk-benefit vote (typically considered the determining FDA approval vote), we anticipate the FDA will follow the panel’s recommendation and approve the Maestro System for the treatment of morbid obesity, which should come in the second half this year
The panel reaffirmed our thesis that EnteroMedics offers a less invasive and safer, yet effective, treatment for the large and under-treated obese population,” Mr. Lewis said, adding that many of the physician panelists labeled the Maestro System as a “much needed “tool in the toolbox” to address a large gap within the obesity treatment paradigm."
Not sure about the other two. I'm sure you can find their reasoning of you look hard enough.
I'm guessing and rightfully so other companies in the space have left investors leery. This is where "i say" they should be re-thinking things. I view ETRM much differently than I do other companies in the space. ETRM is a technology company for one! We are not dealing with pills which have multiple side affects. Doctors don't seem convinced pills work yet, and act like they're scared to death of the side affects that p+f had years ago. Consumers also don't seem interested either being they have probably already tried one or several of the hundreds of pills already on the market.
Vbloc on the other hand is very safe and for the morbidly obese which diet and exercise doesn't work for in most cases. These people can barley walk let alone exercise which is what's required to lose weight with pills (it's on the label). Doctors probably know from viewing the patient and their history if they would do what's required to lose the weight (diet, exercise) which in most cases patients will not. Therefore they're not having the discussions with the patients about the new pills on the market. This is why you see the pill makers pushing the the ad campaign to doctors hoping they will have a discussion with their patient about their weight. Eisai is spending allot of money on this very subject hoping Doctors will prescribe BELVIQ.
I really believe there's going to be allot of folks who miss this boat. But honestly if the pps where to take off to much from here I would be a little concerned that on approval if approved they would just push it back down. But that shouldn't happen if we are down here at this level on approval. We will have no where to go but UP as partnerships, licensing deals ect... become almost certain.
The timing for approval couldn't be more perfect as we enter peak season for weight loss. Lines have already formed just awaiting the all important decision. With approval the possibility's then become endless for this company "partnerships, licensing deals, buy-out" ETRM should be up allot more on just pure speculation alone! $100 market cap at this stage is just ABSURD!!! Hopefully what we've been watching is consolidation rather than traders playing ping pong!
I think this is what allot of people are overlooking. I know I have some concerns with it. I wonder if they've thought about cutting the cost and doing away with freebies.
No doubt the Vagus nerve has become a hot topic as of late. Just waiting now for the all important FDA decision which has sounded positive thus far. With approval opens the doors to an endless land of opportunity's. Glad to see you're still posting and thanks for sharing your find.
Biotia I will try to get along with you one more time for sake of the board.
"We believe that EnteroMedics is about to gain FDA clearance for VBLOC" is the "HEADLINE" I was seeing. I had not even read the article yet. After I read the article I put up the source for all to read themselves. And by the way it was updated news. Canaccord did an interview in which the the source made public on that day THAT"S NEWS!! As far as me saying there are "several" other sources picking up the publication THEY DID. I didn't say there was anything new! I said they where PICKING UP THE STORY! I think it's great when people share ideas, research and opinions on these boards so we agree there. So again yes there are other sources picking up the story. Google "Shifts from High Gear by The Life Sciences Report" and tell me what you see! GL
Gary i removed my original response because I mentioned someone's name we don't need here to bash on a daily basis. Anyways I'm doing good just waiting like all of us are. GL
I checked it out as soon as you posted it. I'm getting icthy finger again myself, but want to see a couple things happen first. Hope I don't miss anything spectacular!
Really? I didn't exaggerate anything!!! All I did was note the headline i was seeing on the intraday pop. ""We believe that EnteroMedics is about to gain FDA clearance for VBLOC" NOT MY WORDS but THEIRS. Another poster posted the whole story.
To your question "Who are they" Go look for yourself
We get through $1.60 with good volume and it's off to the races in my opinion. That's where I think shorts start covering!